Interaction between PON1 and population density in amyotrophic lateral sclerosis

被引:13
作者
Diekstra, Frank R. [1 ]
Beleza-Meireles, Ana [1 ]
Leigh, Nigel R. [1 ]
Shaw, Christopher E. [1 ]
Al-Chalabi, Ammar [1 ]
机构
[1] Kings Coll London, Inst Psychiat, MRC, Ctr Neurodegenerat Res, London SE5 8AF, England
基金
英国医学研究理事会;
关键词
amyotrophic lateral sclerosis; gene-environment interaction; motor neuron disease; paraoxonase; population density; GENE-ENVIRONMENT; SPORADIC ALS; PARAOXONASE; POLYMORPHISMS; DISEASE; RISK;
D O I
10.1097/WNR.0b013e32831af220
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Paraoxonase polymorphisms have been associated with amyotrophic lateral sclerosis (ALS). Paraoxonases are detoxifying enzymes involved in the metabolism of organophosphates. We tested the hypothesis that genetic variation within paraoxonase genes would interact with the environmental exposure to paraoxonase substrates. We used population density in the location of residence of ALS patients as a surrogate marker for environmental exposure. Paraoxonase genotypes at previously associated single nucleotide polymorphisms rs662, rs854560, rs6954345, and rs11981433 were studied in 98 patients from the South East England ALS population-based register. A case-only analysis was carried out and median population density was used to categorize patients into rural or urban environments. We found a significant interaction with population density for marker rs854560 (L55M) in ALS. NeuroReport 20:186-190 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:186 / 190
页数:5
相关论文
共 25 条
[1]
Amyotrophic lateral sclerosis in south-east England: A population-based study - The south-east England register for amyotrophic lateral sclerosis (SEALS registry) [J].
Abhinav, K. ;
Stanton, B. ;
Johnston, C. ;
Hardstaff, J. ;
Orrell, R. W. ;
Howard, R. ;
Clarke, J. ;
Sakel, M. ;
Ampong, M. -A. ;
Shaw, C. E. ;
Leigh, P. N. ;
Al-Chalabi, A. .
NEUROEPIDEMIOLOGY, 2007, 29 (1-2) :44-48
[2]
ADKINS S, 1993, AM J HUM GENET, V52, P598
[3]
Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype [J].
Brophy, VH ;
Jarvik, GP ;
Richter, RJ ;
Rozek, LS ;
Schellenberg, GD ;
Furlong, CE .
PHARMACOGENETICS, 2000, 10 (05) :453-460
[4]
Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression [J].
Brophy, VH ;
Jampsa, RL ;
Clendenning, JB ;
McKinstry, LA ;
Jarvik, GP ;
Furlong, CE .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (06) :1428-1436
[5]
Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging [J].
Cherki, Mounia ;
Berrougui, Hicham ;
Isabelle, Maxim ;
Cloutier, Martin ;
Koumbadinga, Geremy Abdull ;
Khalil, Abdelouahed .
EXPERIMENTAL GERONTOLOGY, 2007, 42 (08) :815-824
[6]
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players [J].
Chiò, A ;
Benzi, G ;
Dossena, M ;
Mutani, R ;
Mora, G .
BRAIN, 2005, 128 :472-476
[7]
Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis [J].
Cronin, Simon ;
Greenway, Matthew J. ;
Prehn, Jochen H. M. ;
Hardiman, Orla .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (09) :984-986
[8]
The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin [J].
Davies, HG ;
Richter, RJ ;
Keifer, M ;
Broomfield, CA ;
Sowalla, J ;
Furlong, CE .
NATURE GENETICS, 1996, 14 (03) :334-336
[9]
The structure of haplotype blocks in the human genome [J].
Gabriel, SB ;
Schaffner, SF ;
Nguyen, H ;
Moore, JM ;
Roy, J ;
Blumenstiel, B ;
Higgins, J ;
DeFelice, M ;
Lochner, A ;
Faggart, M ;
Liu-Cordero, SN ;
Rotimi, C ;
Adeyemo, A ;
Cooper, R ;
Ward, R ;
Lander, ES ;
Daly, MJ ;
Altshuler, D .
SCIENCE, 2002, 296 (5576) :2225-2229
[10]
Excess incidence of ALS in young Gulf War veterans [J].
Haley, RW .
NEUROLOGY, 2003, 61 (06) :750-756